Cambridge Healthtech Institute’s 3rd Annual

Analytics-Driven Feasibility, Site Selection and Study Activation

Improving Protocol Development, Global Site Selection, Feasibility and Site Management

14-15 October 2020

 

We are pleased to announce production of Cambridge Healthtech Institute’s Analytics-Driven Feasibility, Site Selection and Study Activation: Improving Protocol Development, Global Site Selection, Feasibility and Site Management being held 14-15 October 2020 at the Hotel Barceló Sants in Barcelona, Spain. Feasibility assessment, protocol development, and site selection are arguably the most critical components of the clinical trial process. Performing these first steps effectively will significantly impact the likelihood of completing the trial on time and within budget. Innovative data and analytics capabilities, new protocol development and feasibility assessment processes, and novel approaches to stakeholder communication and collaboration are improving clinical trial timelines and outcomes and driving trial success.

The gathering will be part of the Summit for Clinical Trials Operations Executives (SCOPE) Europe, a two-day event made up of shared plenary keynotes from biopharma thought leaders, 5 conferences focused on specific issues and functions within the clin ops, innovation and research enterprise, informal and interactive breakout discussion groups, and networking. Please see the overall program map below for 2020. Topics to be discussed at the Analytics-Driven Feasibility, Site Selection and Study Activation conference include:

  • Data science in protocol optimization 
  • Incorporating site input into the protocol development process 
  • Building and implementing a data-driven site selection approach 
  • New technologies and AI-enabled solutions in clinical trial feasibility and site selection 
  • Tools and strategies to improve site activation and study start-up 
  • Best practices in protocol design to reduce amendments and improve trial success

If you are interested in presenting, please submit a speaking proposal for review by 20 March 2020.

We are looking for actual implementation stories and lessons learned, not theoretical talks. Co-presentations featuring speakers from different departments involved in the project are encouraged.

Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academic/hospital centers. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

If you are interested in presenting, please submit a speaking proposal for review by 20 March 2020.

For more details on the conference, please contact:
Bridget Kotelly
Conference Producer
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.5404
Email: bkotelly@cambridgeinnovationinstitute.com

For partnering and sponsorship information, please contact:

Companies A-K:
Ilana Quigley
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.5457
Email: iquigley@healthtech.com

Companies L-Z:

Patty Rose
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.1349
Email: prose@healthtech.com

For media and association partnerships, please contact:

Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)
Phone: (+1) 781.972.5456
Email: rhandy@healthtech.com